| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | A New Drug Design Targeting the Adenosinergic System for Huntington's Disease | Huang, N-K; Lin, J-H; Lin, J-T; Lin, C-I; Liu, E, M; Lin, C-J; Chen, W-P; Shen, Y-C; Chen, H-M; Chen, J-B; Lai, H-L; Yang, C-W; Chiang, C-M; Wu, Y-S; Chang, C; Chen, J-F; Fang, J-Mx; Lin, Y-Lx; Chern, Y | PLoS ONE 6, e20934 | | | |
| 2015 | Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington’s disease iPSCs | Chiu, F-L; Lin, J-T; Chuang, C-Y; Chien, T; Chen, C-M; Chen, K-H; Hsiao, H-Y; Lin, Y-S; Chern, Y; Kuo, HC | Human Molecular Genetics 24(21), 6066-6079 | | | |
| 2009 | Novel regulation of adenylyl cyclases by direct protein-protein interactions: insights from Sanpin and Ric8a | Wang, S-C; Lin, J-T; Chern, Y | NeuroSignals 17(3), 169-180 | | | |
| 2011 | Type VI adenylyl cyclase (AC6) regulates neurite extension by binding to Snapin and Snap25. | Wu, C-S; Lin, J-T; Chien, C-L; Chang, W-C; Lai, H-L; Chang, C-P; Chern, Y | MOLECULAR AND CELLULAR BIOLOGY 31(24), 4874-4886 | | | |
